Skip to main content
. 2024 Sep 13;12(10):e02831-23. doi: 10.1128/spectrum.02831-23

TABLE 3.

Validation of the four selected gene signatures: discriminating patients with bacterial (n = 8) from viral and SARS-CoV-2 (n = 16) etiologies

Study Sensitivity in % (95%CI) Specificity in % (95%CI) AUC (95%CI) Accuracy in %
Xu et al.
  2-gene signature
  IFI44L, PI3
75.0 (34.9–96.8) 93.8 (69.8–99.8) 0.91 (0.78–0.1.00) 87.5
Li et al.
  3-gene signature
  HERC6, IGF1R, NAGK
87.5 (47.4–99.7) 93.8 (69.8–99.8) 0.97 (0.91–0.1.00) 91.7
Rao et al.
  8-gene signature
  EPI3, FCER1A, HESX1, ICAM1, IFI27, JUP, SMARCD3, SUCLG2
100.0 (63.1–100.0) 100.0 (79.4–100.0) 0.99 (0.99–1.00) 100.0
Ravichandran et al.
  10-gene signature
  DNMT1, EPSTI1, GYG1, HK3, IFI27, IFI44, ISG15, MMP9, MX1, PRF1
100.0 (63.1–100.0) 100.0 (79.4–100.0) 0.99 (0.99–1.00) 100.0